Intracranial Aneurysm Market to Reach $2.7 Billion by 2031, Fueled by Rise in Minimally Invasive Treatments

PORTLAND, OR, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- The global intracranial aneurysm market is projected to grow from $1.3 billion in 2021 to $2.7 billion by 2031, at a CAGR of 7.6%. This growth is primarily driven by the increasing prevalence of cerebrovascular conditions, aging demographics, and advancements in minimally invasive treatment technologies such as endovascular coiling and flow diverters.

🧠 What Is an Intracranial Aneurysm?
An intracranial (or cerebral) aneurysm is a weak, bulging area in an artery in the brain, often resembling a balloon or blister. If this bulge ruptures, it leads to subarachnoid hemorrhage (SAH)—a life-threatening type of stroke. Aneurysms may remain asymptomatic until rupture, and their causes range from hypertension and smoking to genetic conditions and aging.

Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A10205

🚀 Key Market Growth Drivers
Rising incidence of brain aneurysms globally

~6.5 million people in the U.S. have unruptured brain aneurysms

Increased demand for minimally invasive procedures

Preference for endovascular coiling over open surgery

Technological innovation

Next-gen flow diverters and embolization devices

Growing geriatric population, especially in developed and developing nations

Higher prevalence among women, especially over age 55

🩺 Market Challenges
💰 High cost of treatment and surgical equipment

⚠️ Risk of complications with open brain surgery (e.g., craniotomy)

🧠 Lack of awareness in low-resource settings

🔬 Market Segmentation Highlights
🧩 By Type
Endovascular Coiling (Dominant Segment, 2021)

Minimally invasive and widely adopted

Flow Diverters (Fastest Growing Segment)

Rapid adoption due to enhanced precision and lower complication rates

Surgical Clipping & Others

Traditional method; still used in select cases

🏥 By End User
Hospitals (Leading Segment)

Equipped with neurosurgical ICUs and advanced imaging

Clinics (Rising Demand)

Preference for outpatient care and minimally invasive interventions

🌍 By Region
North America (Largest Share in 2021)

Advanced healthcare infrastructure

Presence of key market players like Medtronic, Stryker, MicroVention

Asia-Pacific (Fastest Growing)

High prevalence of hypertension and smoking

Expanding medical tourism in India and China

Rising demand for minimally invasive surgery

🏢 Leading Companies in the Market
Medtronic PLC

Stryker Corporation

B. Braun Melsungen AG

Terumo Corporation (MicroVention)

Integra LifeSciences Holdings Corp.

MicroPort Scientific Corporation

Mizuho Medical Inc.

Evonos GmbH & Co. KG

Spiegelberg GmbH & Co. KG

Delta Surgical

📌 Quick Facts & Summary Bullet Points
💡 Market Size: $1.3B (2021) → $2.7B (2031)

📈 CAGR: 7.6% (2022–2031)

🩻 Top Treatment: Endovascular coiling

🌐 Top Region: North America; Fastest Growth: Asia-Pacific

👵 Key Patient Segment: Women over 55 years

💊 Innovation Trend: Flow diverters & embolization devices

🧪 Opportunity Hotspots: India, China, Mexico, Brazil (due to affordable neurosurgery)

⚠️ Top Risk Factors: Hypertension, smoking, unhealthy lifestyle

Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/A10205

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X